Clarifying the benefits of sonocrystallisation

David Hipkiss explains the benefits for pharmaceutical manufacturers of using Prosonix’ sonocrystallisation technology.

David Hipkiss explains the benefits for pharmaceutical manufacturers of using Prosonix’ sonocrystallisation technology.

Related news

Follow us

Products

View more

Webinars

Upcoming editorial webinars

12 Jun 2024 Wed Webinar Diversity: Increasing trial inclusivity

On-demand webinars

Headlines

South Rampart Pharma's quest to deliver innovative non-opioid pain solutions
Inceptua improves access to medicine for serious gram-negative bacterial infections in LATAM
Indica Labs'platform cleared by FDA, enhancing pathologists' diagnostic capabilities
Roquette solving toughest drug development challenges with new capsules
First oral treatment for chronic kidney disease launched in China by Everest Medicine
Real-life data highlights need for patient-centered management of unhealthy cholesterol
Sanofi's €1BN investment to enhance health sovereignty in France
PrecisionLife and Metrodora Institute spearhead clinical trials for ME/CFS and Long COVID patients
Novigenix collaborates with IMMUcan Consortium using AI platform to fight cancer
Report highlights challenges facing life sciences sector amid economic turbulence